SCHEMBL25112571

SCHEMBL25112571

N#Cc1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc(-c6cc7ccc8cccc9c%10cccc%11ccc%12cccc(c(c6)c7c89)c%12c%11%10)cc5)cc4)n3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.43
MEN1 O00255 4/20 0.43
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 4/20 0.43
CYP3A4 P08684 4/20 0.43
LMNA P02545 4/20 0.43
CYP2C19 P33261 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
HSD17B10 Q99714 3/20 0.43
CYP2D6 P10635 3/20 0.43
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.43
ABCG2 Q9UNQ0 11/20 0.42
ABCB1 P08183 5/20 0.42
MAPK1 P28482 2/20 0.40
TP53 P04637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
ABCC1 P33527 2/20 0.39
MYC P01106 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112686 1.00 CYP1A2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112662 1.00 CYP1A2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112687 1.00 CYP1A2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112685 0.99 CYP1A2 (0.44) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112665 0.99 ABCG2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112660 0.99 ABCG2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112583 0.98 CYP1A2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112582 0.98 CYP1A2 (0.43) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112581 0.96 CYP1A2 (0.41) CYP1A2MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL25112567 0.96 ABCG2 (0.45) CYP1A2MEN1ALDH1A1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CYP1A2 1265/4885MEN1 205/4885ALDH1A1 192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.